As a part of our commitment to expanding access to pharmacometrics education, we hosted a webinar on malarial vaccine modeling.
Agenda
Malaria therapeutic options and role of modeling
Dr Steven E. Kern works at the Bill and Melinda Gates Foundation where he directs quantitative analyses that support program strategies for therapeutic projects that the foundation funds.
Simulation of RTS,S Vaccine anti-CSP Titer and Protection Against Malaria
Dr Michael G. Dodds is an engineer applying mathematical models to optimize the development of drugs and vaccines by pharmaceutical product developers in global health.
Pharmacometrics Africa: Capacity development programs
Ms Aida N. Kawuma is a pharmacist and doctoral student investigating pharmacokinetics and pharmacodynamics of dolutegravir in pregnancy, neonates and special populations.
Meeting Host & Moderator
Dr Colin Pillai is a clinical pharmacologist and advisor to the Bill & Melinda Gates Foundation on capacity development for global health
Files for this webinar are available here.